YDES

YD Bio Ltd is a biotechnology company within the healthcare sector. Its market capitalization stands at $894.21M, with revenue of $510,360 (TTM). The number of employees is not disclosed. The company's financial health is characterized by negative profitability metrics, including a gross margin of 30.4%, operating margin of -444.6%, and profit margin of -276.6%. Returns on equity and assets are also negative, at -42.7% and -25.4%, respectively. The balance sheet shows debt of $22,265 and cash of $3.13M, resulting in a debt-to-equity ratio of 0.34. The company's valuation context is marked by a price-to-book ratio of 2.77 and a price-to-sales ratio of 1752.12. Revenue growth has been substantial, with an increase of 95.6% year-over-year (YoY). The current ratio stands at 13.18.